About this trial
To compare mean pain score between two group of participants undergoing post operative pain management after single visit root canal treatment: one group receiving NSAIDs alone and the other receiving a combination of NSAIDs and an anxiolytic medication i.e alprazolam.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients aged between 18-60 years
healthy patients with ASA classification I and II
Teeth with symptomatic irreversible pulpitis
Disqualifiers
patient suffering from systemic disease that requires antibiotics
pregnant or lactating mothers
teeth with periapical radiolucency
teeth with severe periodontitis
Trial design
Parallel
Treatments tested in this trial
Brufen and alprazolam
Combination productsecond group in the study will be prescribed 400mg ibuprofen and 0.5mg alp tablet for management of post endodontic pain after root canal treatment
Brufen
Drugone group in the study will be prescribed 400mg ibuprofen for management of post endodontic pain after root canal treatment
Treatment groups
Trial outcomes
Primary outcomes
pain levels
patients will be randomly assigned to one of two groups: * Group 1: Ibuprofen 400 mg (Abbott Brufen) * Group 2: Ibuprofen 400 mg (Abbott Brufen) + Alprazolam 0.5 mg (Hilton Pharma Alp) Pain Assessment Participants will be provided with a pain diary containing a 10 cm Visual Analogue Scale (VAS) ranging from 0 (no pain) to 10 (worst possible pain). They will record their pain intensity at 6, 12, and 24 hours after treatment. Pain diaries will be collected during the one-week follow-up visit. Data will be used to compare mean VAS scores between groups to evaluate the efficacy of the two analgesic regimens.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.